Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3445 |
Aristolactam BIII
|
PAFR | GPCR/G Protein |
Aristolactam BIII possesses anti-platelet aggregation activity in vitro, it also shows significant cytotoxic activity (IC50 values < 4 microg/mL) against P-388, HT-29 and A549 cell lines in vitro. |